Search Results - "GUAZA, Carmen"

Refine Results
  1. 1
  2. 2

    The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis by Benítez-Fernández, Rocio, Gil, Carmen, Guaza, Carmen, Mestre, Leyre, Martínez, Ana

    “…Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune and degenerative disease with axonal damage and demyelination as its main features. Its dual…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis by Navarrete, Carmen, García-Martin, Adela, Garrido-Rodríguez, Martín, Mestre, Leyre, Feliú, Ana, Guaza, Carmen, Calzado, Marco A., Muñoz, Eduardo

    Published in Neurobiology of disease (01-09-2020)
    “…Multiple Sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes in the spinal cord and the brain. Natural and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review by Mecha, Miriam, Carrillo-Salinas, Francisco J, Feliú, Ana, Mestre, Leyre, Guaza, Carmen

    Published in Frontiers in cellular neuroscience (19-02-2020)
    “…The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, leading to the approval of the first cannabis-based therapy…”
    Get full text
    Journal Article
  7. 7

    CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation by Hernangómez, Miriam, Mestre, Leyre, Correa, Fernando G., Loría, Frida, Mecha, Miriam, Iñigo, Paula M., Docagne, Fabian, Williams, Richard O., Borrell, José, Guaza, Carmen

    Published in Glia (01-09-2012)
    “…The endocannabinoid anandamide (AEA) is released by macrophages and microglia on pathological neuroinflammatory conditions such as multiple sclerosis (MS)…”
    Get full text
    Journal Article
  8. 8

    Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis by Mestre, Leyre, Carrillo-Salinas, Francisco Javier, Mecha, Miriam, Feliú, Ana, Espejo, Carmen, Álvarez-Cermeño, José Carlos, Villar, Luisa María, Guaza, Carmen

    Published in Frontiers in immunology (14-06-2019)
    “…Gut microbiota dysbiosis has been implicated in MS and other immune diseases, although it remains unclear how manipulating the gut microbiota may affect the…”
    Get full text
    Journal Article
  9. 9

    Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis by Mecha, Miriam, Yanguas-Casás, Natalia, Feliú, Ana, Mestre, Leyre, Carrillo-Salinas, Francisco Javier, Riecken, Kristoffer, Gomez-Nicola, Diego, Guaza, Carmen

    Published in Journal of neuroinflammation (19-03-2020)
    “…The participation of microglia in CNS development and homeostasis indicate that these cells are pivotal for the regeneration that occurs after demyelination…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis by Carrillo-Salinas, Francisco J, Navarrete, Carmen, Mecha, Miriam, Feliú, Ana, Collado, Juan A, Cantarero, Irene, Bellido, María L, Muñoz, Eduardo, Guaza, Carmen

    Published in PloS one (01-04-2014)
    “…Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases. A cannabigerol…”
    Get full text
    Journal Article
  14. 14
  15. 15

    CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model by Hernangómez, Miriam, Klusáková, Ilona, Joukal, Marek, Hradilová-Svíženská, Ivana, Guaza, Carmen, Dubový, Petr

    Published in Journal of neuroinflammation (18-02-2016)
    “…Interaction of CD200 with its receptor CD200R has an immunoregulatory role and attenuates various types of neuroinflammatory diseases. Immunofluorescence…”
    Get full text
    Journal Article
  16. 16

    A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis by Calvo-Barreiro, Laura, Eixarch, Herena, Ponce-Alonso, Manuel, Castillo, Mireia, Lebrón-Galán, Rafael, Mestre, Leyre, Guaza, Carmen, Clemente, Diego, Del Campo, Rosa, Montalban, Xavier, Espejo, Carmen

    Published in Cells (Basel, Switzerland) (07-04-2020)
    “…Previous studies in experimental autoimmune encephalomyelitis (EAE) models have shown that some probiotic bacteria beneficially impact the development of this…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The endocannabinoid system is modulated in response to spinal cord injury in rats by Garcia-Ovejero, Daniel, Arevalo-Martin, Angel, Petrosino, Stefania, Docagne, Fabian, Hagen, Carlos, Bisogno, Tiziana, Watanabe, Masahiko, Guaza, Carmen, Di Marzo, Vincenzo, Molina-Holgado, Eduardo

    Published in Neurobiology of disease (01-01-2009)
    “…Abstract Endocannabinoids are lipid mediators with protective effects in many diseases of the nervous system. We have studied the modulation of the…”
    Get full text
    Journal Article
  19. 19

    Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide by Loría, Frida, Petrosino, Stefania, Mestre, Leyre, Spagnolo, Alessandra, Correa, Fernando, Hernangómez, Miriam, Guaza, Carmen, Di Marzo, Vincenzo, Docagne, Fabian

    Published in The European journal of neuroscience (01-08-2008)
    “…Cannabinoids have recently been approved as a treatment for pain in multiple sclerosis (MS). Increasing evidence from animal studies suggests that this class…”
    Get full text
    Journal Article
  20. 20

    Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling by Correa, Fernando, Mestre, Leyre, Docagne, Fabian, Guaza, Carmen

    Published in British journal of pharmacology (01-06-2005)
    “…1 Cannabinoid (CB) receptor agonists have potential utility as anti‐inflammatory drugs for the treatment of many disease conditions. In the present study, we…”
    Get full text
    Journal Article